4//SEC Filing
Dumesnil Simon 4
Accession 0001213900-22-073502
CIK 0001841330other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:34 PM ET
Size
8.4 KB
Accession
0001213900-22-073502
Insider Transaction Report
Form 4
Dumesnil Simon
Director
Transactions
- Award
Common Stock
2022-11-15$1.07/sh+10,000$10,700→ 10,000 total - Award
Common Stock
2022-11-17$1.06/sh+40,000$42,400→ 50,000 total - Award
Stock Option (to acquire Common Stock)
2021-08-02+100,000→ 100,000 totalExercise: $6.00From: 2022-08-02Exp: 2031-08-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 100,000 stock options which have a ten-year term. The option is vested and exercisable with regard to 50,000 shares of Common Stock. The remaining 50% vest, subject to Mr. Dumesnil's remaining employed and in good standing, on August 2, 2023.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001875691
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:34 PM ET
- Size
- 8.4 KB